Hospira appoints Abbott’s Dempsey to the board

Late on Wednesday, Hospira Inc. announced that William Dempsey was voted into the board of directors thus expanding the board of the drug and medical device maker to 11 members.

In 2007, Dempsey, 59, took leave from Abbott Laboratories. As a part of his job portfolio, he was responsible for leading the hospital products business, and chemical and agricultural business. Dempsey later took over the US pharmaceutical business for Abbott and engaged himself for a year by taking charge of its global pharmaceutical business.